EpiVax Wins $600K SBIR Grant to Develop Vaccine Against H. Pylori | GenomeWeb

NEW YORK, May 5 (GenomeWeb News) - The US National Institutes of Health awarded EpiVax a $600,000 Phase I Small Business Innovation Research grant to develop a vaccine to Helicobacter pylorus, a common cause of peptic ulcers, the company said last week.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.